COMP <GO>
TWST vs TECH // FREE CASH FLOW YIELD
Twist Bioscience Corporation (NASDAQ) VS. Bio-Techne Corp (NASDAQ) • 15-METRIC TALLY: TWST 6
— TECH 7
▲ FREE CASH FLOW YIELD LEADER: TECH
LAST: $152.78 (-11.92%) • MKT CAP: $11.50B
fcf-yield
-0.66%
LAST: $72.66 (-0.07%) • MKT CAP: $11.40B
fcf-yield
2.25%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TWST VS. TECH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TWST | TECH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 94.20% | 64.80% | +29.40 | TWST | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.70% | 3.40% | -15.10 | TECH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 91.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -0.66% | 2.25% | -2.91 | TECH | /fcf-yield <GO> |
| Operating Margin | -4.20% | 8.40% | -12.60 | TECH | /operating-margins <GO> |
| Net Profit Margin | -2.40% | 6.00% | -8.40 | TECH | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | 5.20% | +11.30 | TWST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.44% | -0.44 | TECH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 7.12 | +18.88 | TWST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TECH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.2 | 59.3 | -2.10 | TECH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.88 | +0.10 | TWST | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 140.0x | -119.00 | TWST | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.50B | $11.40B | $97.7M | TWST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TWST REV | TECH REV | TWST GROSS % | TECH GROSS % | TWST FCF | TECH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $1.22B | — | 64.8% | -$75.6M | $256.6M |
| FY 2024 | $0 | $1.16B | — | 66.4% | -$69.2M | $236.1M |
| FY 2023 | $0 | $1.14B | — | — | -$142.5M | $203.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TWST // BETA 0.98
TECH // BETA 0.88